Neighborhood factors related to financial stress are linked to worse breast cancer outcomes
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Jun-2026 06:15 ET (1-Jun-2026 10:15 GMT/UTC)
New research published this week in JAMA Network Open connects multiple residential factors generally associated with financial strain, such as high housing costs and crowded households, to worse overall outcomes among breast cancer survivors. Led by investigators at VCU Massey Comprehensive Cancer Center, the findings could help inform innovative strategies to increase health care access and ease economic stress for a variety of patients in need.
Severely injured patients are more likely to survive if they are initially treated by an emergency medical services (EMS) clinician who sees a high number of trauma patients, rather than a clinician in a quieter area even if they have been on the job longer, new research by UPMC and University of Pittsburgh surgeon-scientists reveals.
Most chronic diseases don’t begin with obvious symptoms or dramatic warning signs. Instead, they develop quietly over many years, as small changes accumulate in the body. A new perspective from researchers at the Buck Institute for Research on Aging notes that modern medicine often waits until disease is well underway, arguing that new technologies could help detect risk much earlier, when prevention may be most effective.
The human genome is a long sequence of DNA scattered with innumerable genetic variants that distinguish us. Extracting information from large biobank datasets about complex traits, influenced by thousands or millions of variants, remains a challenge. Using human height as a model, researchers at the Institute of Science and Technology Austria (ISTA) have now tackled this problem and developed an enhanced algorithm, published in Cell Genomics, with potential applications in personalized medicine—and even at crime scenes.
A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection.
An experimental vaccine administered to the mucosal lining of the colon protected against illness, death, tissue damage and infection recurrence. The findings, reported Feb. 18 in the journal Nature, represent a major step forward for vaccine development for C. diff, the leading cause of health care- and antibiotic-associated infection.